BSE
Your Result on : Company News
Fredun Pharmaceuticals Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
539730
ISIN Demat
INE194R01017
Book Value (Rs)
163.1433353
NSE Symbol
N.A
Divident Yield %
0.02
Market Cap
(Rs In Cr.)
1,533
P/E (TTM)
46.15
EPS (TTM)
20.08
Face Value
(Rs)
10
Date Heading
09-Jun-26 Fredun Pharmaceuticals to convene AGM
29-May-26 Fredun Pharmaceuticals consolidated net profit rises 79.67% in the Mar
25-May-26 Board of Fredun Pharmaceuticals approves bonus issue of 2:1
25-May-26 Board of Fredun Pharmaceuticals recommends final dividend
25-May-26 Fredun Pharmaceuticals standalone net profit rises 56.58% in the March
16-May-26 Fredun Pharmaceuticals to announce Quarterly Result
29-Apr-26 Fredun Pharmaceuticals sets up its 5th manufacturing unit in Palghar
09-Apr-26 Fredun Pharmaceuticals allots 40,000 equity shares on conversion of wa
13-Feb-26 Fredun Pharmaceuticals standalone net profit rises 96.62% in the Decem
31-Jan-26 Fredun Pharmaceuticals to convene board meeting
20-Jan-26 Fredun Pharmaceuticals to convene EGM
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)